Dysfunction of von-Hippel Lindau factor causes reduced degradation of HIF leading to renal cancer. Hypoxia-inducible factor-prolyl hydroxylase enzyme inhibitors also lessen HIF destruction and could therefore increase renal cancer

書誌詳細
出版年:Frontiers in Pharmacology
第一著者: Helge Waldum
フォーマット: 論文
言語:英語
出版事項: Frontiers Media S.A. 2023-06-01
主題:
オンライン・アクセス:https://www.frontiersin.org/articles/10.3389/fphar.2023.1170796/full